SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-049195
Filing Date
2024-04-26
Accepted
2024-04-26 16:25:09
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq Description Document Type Size
1 ARS antx-ars-2023.pdf ARS 1803140
  Complete submission text file 0000950170-24-049195.txt   2485062
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Filer) CIK: 0001880438 (see all company filings)

IRS No.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41331 | Film No.: 24884214
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)